MDPPS (Medical Device Post Production Services) serves overseas manufacturers looking to bring medical devices to the U.S. market, offering FDA-related US Agent, FDA Registered Initial Importer, and strategic consulting services. Based on the website, its core value is not a software tool, but helping clients understand and execute the U.S. medical device import, registration, documentation, and compliance process.
Its services are focused on three areas: US Agent, Initial Importer, and Strategic Consulting. The FAQ covers many practical scenarios, such as which supply-chain entities need FDA Establishment Registration, whether domestic distributors need to register, how to reduce U.S. import delays, what to do after shipments are detained, and how to complete missing information on commercial invoices. MDPPS can also coordinate with carriers and customs brokers to provide required materials to customs authorities or the FDA. Its strategic consulting covers quality management systems, device development and manufacturing, and regulatory and standards compliance.
The website does not disclose specific plans, service pricing, payment methods, or contract models. It only mentions that the 2024 FDA Establishment Registration fee is USD 9,280, and emphasizes that using its Initial Importer service may be more cost-effective than setting up a U.S. office. From a SaaS or enterprise software perspective, the pages do not show an online dashboard, automated workflows, team permissions, data security certifications, APIs, developer documentation, or cloud/self-hosted deployment options. Therefore, it should not be treated as a standard SaaS product.
Its strengths are its vertical focus and practical experience around FDA and customs procedures for bringing medical devices into the U.S. The FAQ clearly explains issues such as import delays, detained shipments, and missing documentation, making it suitable for manufacturers that lack local U.S. compliance resources. Its drawbacks are limited public information, the absence of clear pricing, delivery SLAs, customer cases, and software capability descriptions. The crawled content also shows multiple missing-page notices, which affects information completeness.
MDPPS is suitable for companies planning to export medical devices to the United States, needing a US Agent or Initial Importer, or currently dealing with FDA/customs import documentation issues. The main content does not provide information on access from China, and payment methods are not disclosed. If Chinese companies are evaluating it, they should focus on confirming cross-border contracts, payment arrangements, time-zone communication, whether Chinese-language materials can be supported, and how its pricing compares with domestic regulatory consulting firms or other FDA US Agent providers.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mdpps-inc.com official site.
mdpps-inc.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach mdpps-inc.com directly.